Longitudinal Hemodynamic Changes in Pediatric Patients with Severe Pulmonary Arterial Hypertension (PAH) on Prostanoid Therapy

被引：0
|
作者：
Siehr, S. L. [1 ]
Ivy, D. [2 ]
Miller-Reed, K. [2 ]
Ogawa, M. [1 ]
Rosenthal, D. [1 ]
Feinstein, J. A. [1 ]
机构：
[1] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA
[2] Univ Colorado Denver, Childrens Hosp, Aurora, CO USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2011年 / 30卷 / 04期
关键词：
D O I：
10.1016/j.healun.2011.01.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
197
引用
收藏
页码：S72 / S72
页数：1
相关论文
共 50 条
  • [41] Longitudinal changes in risk status in pulmonary arterial hypertension
    Bouzina, Habib
    Radegran, Goran
    Butler, Oisin
    Hesselstrand, Roger
    Hjalmarsson, Clara
    Holl, Katsiaryna
    Jansson, Kjell
    Klok, Rogier
    Soderberg, Stefan
    Kjellstrom, Barbro
    [J]. ESC HEART FAILURE, 2021, 8 (01): : 680 - 690
  • [42] Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension
    Frantz, Robert P.
    Benza, Raymond L.
    Kjellstroem, Barbro
    Bourge, Robert C.
    Barst, Robyn J.
    Bennett, Tom D.
    McGoon, Michael D.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (07): : 780 - 788
  • [43] Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
    Amsallem, Myriam
    Bagherzadeh, Shadi P.
    Boulate, David
    Sweatt, Andrew J.
    Kudelko, Kristina T.
    Sung, Yon K.
    Feinstein, Jeffrey A.
    Fadel, Elie
    Mercier, Olaf
    Denault, Andre
    Haddad, Francois
    Zamanian, Roham
    [J]. PULMONARY CIRCULATION, 2020, 10 (04)
  • [44] Long-term sitaxsentan therapy in Pulmonary Arterial Hypertension (PAH)
    Horn, E
    Langleben, D
    Frost, A
    Hill, N
    McLaughlin, V
    Oudiz, R
    Dixon, RAF
    Barst, RJ
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 : 466 - 466
  • [45] Real-world Use of Upfront Combination Therapy in Pulmonary Arterial Hypertension (PAH) Patients
    Paoli, C.
    Tang, W.
    Panjabi, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [46] Effect of Riociguat on Pulmonary Arterial Compliance in Patients With Pulmonary Arterial Hypertension (PAH) in the Respite Study
    Thenappan, Thenappan
    Hoeper, Marius
    Corris, Paul
    Ghofrani, Hossein-Ardeschir
    Klinger, James
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond
    [J]. CHEST, 2017, 152 (04) : 1005A - 1006A
  • [47] Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study
    Hoeper, Marius M.
    Corris, Paul A.
    Ghofrani, Hossein-Ardeschir
    Klinger, James R.
    Langleben, David
    Naeije, Robert
    Simonneau, Gerald
    Jansa, Pavel
    Rosenkranz, Stephan
    Grunig, Ekkehard
    Scelsi, Laura
    Meier, Christian
    Busse, Dennis
    Benza, Raymond L.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [48] Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomes
    Zheng, Yaguo
    Yang, Tao
    Chen, Guo
    Hu, Enci
    Gu, Qing
    Xiong, Changming
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (01) : 13 - 21
  • [49] Prostanoid therapy for pulmonary arterial hypertension: a meta-analysis of survival outcomes
    Yaguo Zheng
    Tao Yang
    Guo Chen
    Enci Hu
    Qing Gu
    Changming Xiong
    [J]. European Journal of Clinical Pharmacology, 2014, 70 : 13 - 21
  • [50] RISK ASSESSMENT IN PEDIATRIC PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH): APPLICATION OF THE REVEAL 2.0 RISK CALCULATOR
    Ivy, David
    Berman, Erika
    Elliott, Rosenzweig C.
    Farber, Harrison
    Frantz, Robert
    Gomberg-Maitland, Mardi
    Mu, Yi
    Zhao, Carol
    Kenny, Ellen
    Selej, Mona
    Benza, Raymond
    [J]. CHEST, 2019, 156 (04) : 169A - 171A
12345